Advanced Blood-Brain Barrier Opening Systems for Enhanced Drug Delivery

Publication ID: 24-11857812_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Blood-Brain Barrier Opening Systems for Enhanced Drug Delivery,” Published Technical Disclosure No. 24-11857812_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857812_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,812.

Summary of the Inventive Concept

A next-generation system for selectively opening the blood-brain barrier, leveraging cutting-edge technologies such as transcranial magnetic stimulation, low-intensity ultrasound, artificial intelligence, multimodal imaging, optogenetics, and nanorobots to revolutionize drug delivery to the brain.

Background and Problem Solved

The original patent disclosed an ultrasound-guided system for opening the blood-brain barrier. However, this approach has limitations, including the need for precise positioning and potential side effects. The new inventive concept addresses these limitations by introducing novel, synergistic technologies that enable more targeted, efficient, and safe blood-brain barrier opening.

Detailed Description of the Inventive Concept

The advanced blood-brain barrier opening system comprises multiple modules, including transcranial magnetic stimulation, low-intensity ultrasound, and optogenetics. The system utilizes artificial intelligence and multimodal imaging data to generate a personalized brain atlas, identifying target regions for blood-brain barrier opening. The system then applies a combination of focused ultrasound and optogenetics to selectively open the blood-brain barrier in the target region. Additionally, the system features a wearable ultrasound transducer array, a neural signal processing unit, and a machine learning algorithm to predict optimal ultrasound parameters for personalized blood-brain barrier opening. The system can be operated in a closed-loop mode, where real-time imaging feedback adjusts ultrasound parameters to optimize blood-brain barrier opening. Furthermore, the system can be integrated with nanorobot technology, enabling targeted and precise blood-brain barrier opening.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in blood-brain barrier opening by combining synergistic technologies, such as transcranial magnetic stimulation, low-intensity ultrasound, and optogenetics, to achieve enhanced drug delivery. The use of artificial intelligence, multimodal imaging, and machine learning algorithms to personalize and optimize blood-brain barrier opening is a significant departure from the original patent's approach.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different ultrasound frequencies, pulse durations, or intensities. Additionally, the system could be adapted for use in different brain regions or for treating various brain diseases. Variations of the system could also incorporate other technologies, such as electrical stimulation or gene therapy, to further enhance blood-brain barrier opening.

Potential Commercial Applications and Market

The advanced blood-brain barrier opening system has significant commercial potential in the pharmaceutical and biotechnology industries, enabling more effective and targeted drug delivery to the brain. The system could be used to treat a range of brain diseases, including brain cancers, Alzheimer's disease, and Parkinson's disease, addressing a large and growing market.

Field of Art

Biomedical engineering, medical device technologies, focused ultrasound systems for neurological interventions, with expertise in medical imaging, signal processing, and targeted drug delivery techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced degrees in bioengineering, electrical engineering, or medical physics, possessing knowledge of ultrasound technologies, neuroimaging, and blood-brain barrier modulation techniques

Obviousness Rationale

A person having ordinary skill in the art would recognize that the published technical disclosure represents predictable variations and technological extensions of the source patent's ultrasound-based blood-brain barrier opening system. The PTD introduces additional modalities and control mechanisms that are logical technological progressions from the foundational ultrasound transducer approach described in the original patent. These variations represent incremental improvements using known techniques in neural interface technologies and personalized medical interventions.

Obvious Combinations & Variations

Source Patent Element
Ultrasound transducer with multiple treatment elements for brain intervention
PTD Variation
Wearable ultrasound transducer array with machine learning-based parameter optimization
Obviousness Reasoning
A PHOSITA would find it obvious to incorporate machine learning and adaptive parameter selection into an existing ultrasound transducer system, as intelligent optimization of medical device parameters is a known and predictable technique in biomedical engineering
Source Patent Element
Treatment ultrasound transducer with robotic positioning capabilities
PTD Variation
Nanorobot-based system for targeted ultrasound energy delivery
Obviousness Reasoning
Extending the concept of precise targeting from robotic manipulation to nanorobot swarm technology represents a straightforward technological progression that would be obvious to a skilled practitioner exploring miniaturization and targeted intervention techniques
Source Patent Element
Data processor for monitoring and adjusting ultrasound transducer location
PTD Variation
Closed-loop system with real-time imaging feedback and adaptive ultrasound parameter adjustment
Obviousness Reasoning
Implementing a closed-loop control system with real-time imaging feedback is a predictable enhancement to existing medical imaging and intervention technologies, representing an obvious refinement of the source patent's positioning and monitoring approach
Source Patent Element
Ultrasound energy delivery for blood-brain barrier opening
PTD Variation
Multimodal approach combining transcranial magnetic stimulation, low-intensity ultrasound, and optogenetics
Obviousness Reasoning
Combining multiple complementary neurological intervention techniques is a known strategy in biomedical engineering, and a PHOSITA would recognize the potential synergistic effects of integrating different energy modalities for enhanced blood-brain barrier manipulation
Source Patent Element
Treatment system for positioning ultrasound transducer
PTD Variation
Artificial intelligence-generated personalized brain atlas for targeted intervention
Obviousness Reasoning
Utilizing AI and multimodal imaging for personalized medical intervention represents a predictable technological progression in precision medicine, building upon existing imaging and targeting methodologies
35 U.S.C. § 103 Summary: Based on a comprehensive analysis of US Patent 11857812 and the published technical disclosure, a person having ordinary skill in the art would find the disclosed variations obvious and anticipated, rendering potential patent claims covering similar technologies obvious and unpatentable. The incremental technological extensions represent predictable refinements that would be readily conceived by a skilled practitioner in the field of neurological intervention technologies.

Original Patent Information

Patent NumberUS 11,857,812
TitleUltrasound guided opening of blood-brain barrier
Assignee(s)Cordance Medical Inc.